National Health Investors (NYSE:NHI) Releases FY24 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $4.43-$4.44 for the period, compared to the consensus earnings per share estimate of $4.52. National Health Investors also updated its FY 2024 guidance to 4.430-4.440 EPS.

National Health Investors Stock Performance

Shares of NYSE NHI traded up $0.03 during trading hours on Wednesday, reaching $76.76. 870,031 shares of the stock were exchanged, compared to its average volume of 246,682. The stock’s fifty day simple moving average is $80.45 and its 200 day simple moving average is $73.14. The firm has a market capitalization of $3.34 billion, a price-to-earnings ratio of 26.11, a P/E/G ratio of 5.05 and a beta of 1.05. National Health Investors has a 52 week low of $49.25 and a 52 week high of $86.13. The company has a debt-to-equity ratio of 0.91, a quick ratio of 10.27 and a current ratio of 10.27.

National Health Investors (NYSE:NHI) last posted its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share for the quarter, missing analysts’ consensus estimates of $1.10 by ($0.29). National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The firm had revenue of $84.97 million for the quarter, compared to analyst estimates of $64.95 million. During the same period in the prior year, the business posted $1.06 EPS. The firm’s quarterly revenue was up 9.1% compared to the same quarter last year. Sell-side analysts predict that National Health Investors will post 4.48 EPS for the current year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be paid a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 4.69%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is 122.45%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on NHI shares. Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and raised their target price for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. Truist Financial upped their price objective on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Finally, Bank of America began coverage on shares of National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price target for the company. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, National Health Investors has a consensus rating of “Moderate Buy” and an average target price of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.